ACRES Commercial Realty (ACR) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
5 Mar, 2026Executive summary
Closed $571 million in new loan commitments in Q4 2025, resulting in a net portfolio increase of $443.8 million after payoffs and unfunded commitments.
82% of the loan portfolio is multifamily-focused, with 96.8% of loans current on payments as of year-end.
Book value per share increased to $30.01 at December 31, 2025, up from $29.63 in 3Q25 and $28.87 in 4Q24.
Focused originations on multifamily loans, with average loan sizes of $40–$50 million and spreads between 250–325 bps.
Asset management team reduced watchlist assets to a handful, each with plans for positive outcomes.
Financial highlights
GAAP net loss allocable to common shares was $3 million ($0.43 per share) in Q4 2025.
Net interest income rose by $2.3 million sequentially to $10.7 million, driven by new originations.
EAD for Q4 was $0.20 per share excluding the mezzanine loan loss; including it, EAD loss was $0.48 per share.
CRE loan portfolio at par value was $1.8 billion, with $443.8 million in net loan fundings during Q4 2025.
Total liquidity at year-end was $107.9 million, with $684.4 million in available capacity.
Outlook and guidance
Projecting net portfolio growth of $500–$700 million in 2026.
Origination momentum expected to persist into 2026, with plans to provide loans to top sponsors in leading U.S. markets.
Illustrative earnings scenarios project EAD EPS between $0.47 and $2.93 depending on portfolio size and leverage.
Expecting $500 million in repayments, reducing older vintage assets to 15% of portfolio.
Anticipate portfolio mix to shift from heavy multifamily to more diversified asset classes.
Latest events from ACRES Commercial Realty
- Net income and book value rose, with 79% of loans in multifamily and strong liquidity.ACR
Q2 20242 Feb 2026 - Q3 2024 net income rose to $2.8M, book value per share hit $27.92, and liquidity stayed strong.ACR
Q3 202417 Jan 2026 - Q1 net loss, portfolio contraction, and new $939.9M facility amid elevated credit risk.ACR
Q1 202524 Dec 2025 - Book value and EAD rose on asset sales; strong multifamily loans and portfolio growth expected.ACR
Q4 202424 Dec 2025 - Annual meeting to vote on directors, Say on Pay, auditor, and highlight ESG and governance.ACR
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.ACR
Proxy Filing1 Dec 2025 - Q2 2025 saw a net loss, $27.93 book value per share, and a $1.4B CRE loan portfolio.ACR
Q2 202516 Nov 2025 - Q3 net income was $9.8M ($1.34/share), book value rose, and portfolio growth is expected.ACR
Q3 20256 Nov 2025